Alzheimer's disease (AD) is the most common age-related neurodegenerative condition, accounting for up to 70% of all cases of dementia. Prevalence rates of AD range from ~10% of individuals >65 and up to 50% of individuals greater than 85 years of age. Early stages of AD are presented by short-term memory deficits, which steadily decline with worsening dementia clinically manifested by long-term memory loss, language disturbances, changes in personality, attention deficits, hallucinations, and reasoning impairments. The clinical course ranges usually from 5 to 15 years.
Neurofibrillary tangles and neuropil threads are intracellular inclusions principally composed of the microtubule associated protein tau in hyperphosphorylated form. Hyperphosphorylated tau assembles into twisted filaments ultrastructurally seen as paired helical filaments or PHFs, which are immunopositive with AD-specific diagnostic antibodies, such as AT100 or AT8 (Avila et al., 2004) . Tau proteins normally function to stabilize microtubules and are usually seen in somatoaxonal compartments. However during early stages of AD pathogenesis, tau becomes hyperphosphorylated, which weakens its association with microtubules, and is frequently detected in somatodendritic compartments. Thus, hyperphosphorylated tau is unable to stabilize microtubules, mislocalizes to dendritic compartments, and becomes more prone to self-assembly into PHFs (Gendron and Petrucelli, 2009 ).
GENETICS OF ALZHEIMER' DISEASE AND THE AMYLOID HYPOTHESIS
Twenty years ago in 1991, the amyloid hypothesis was postulated that the Aβ deposits are fundamental causes of AD rather than simply pathological hallmarks of the disease (Hardy and Allsop, 1991) . This hypothesis was initially supported by the identification of mutations in APP that co-segregated with early onset familial AD (FAD). Importantly, all of the FAD mutations identified thus far are concentrated near the β-secretase or γ-secretase cleavage sites in APP such that either total Aβ or the more pathogenic Aβ42 peptide is elevated. While γ-secretase cleavage of APP at Aβ residue 42 (Aβ42) is a minor species (~10%) compared to Aβ40 (>80%), numerous studies have shown that Aβ42 is more neurotoxic and is required to efficiently seed the aggregation of Aβ40 (Glabe, 2008) . Furthermore, individuals with trisomy 21 (Down' s syndrome) with an extra copy of the APP gene on chromosome 21 invariably exhibit AD pathology by the 4 th decade of life. Closer examination of Down' s syndrome brains showed that Aβ42 containing senile plaques develop much earlier than neurofibrillary tangles, further supporting the amyloid hypothesis (Hyman, 1992; Hyman et al., 1995) . In 1995, mutations in two homologous genes, Presenilin 1 (PS1) and Presenilin 2 (PS2) were discovered that co-segregated with the most aggressive forms of autosomal dominant early-onset FAD. Thus far, more than 100 different independent FAD mutations in PS1 and PS2 have been identified (St George-Hyslop and Petit, 2005). Further adding support to the amyloid hypothesis, all of the presenilin mutations studied were found to increase the more pathogenic and faster aggregating Aβ42 peptide. Although mutations in APP, PS1, and PS2 account for the majority of early-onset familial AD, the vast majority (>95%) of AD is the late-onset sporadic form that cannot be explained by a single gene defect. Nevertheless, genetic risk factors play an important modulatory role in the onset and severity of AD pathogenesis. The best known and strongest genetic risk factor identified to date is the ε4 allele of the gene coding for Apolipoprotein E (APOE). The APOE ε4 allele increases the risk for AD by ~3-fold among hemizygotes and by ~15-fold among homozygotes (Holtzman, 2001 ). Further supporting the amyloid hypothesis, apoE4 promotes the aggregation of Aβ far more efficiently than apoE3, the most common nonpathogenic variant (Strittmatter et al., 1993) . Therefore, all known and confirmed genetic component of AD either increase total Aβ, the more pathogenic Aβ42 peptide, or aggregation states of Aβ.
SOLUBLE Aβ OLIGOMER HYPOTHESIS AND TAU PATHOLOGY
Recent biochemical and cellular studies on Aβ-induced neurotoxi city have uncovered that distinct states or species of Aβ have different biological properties. First, Aβ42, while at much lower concentration than Aβ40, aggregates faster and seeds the aggregation of Aβ40 (Glabe, 2008) . Transgenic mice engineered to produce only Aβ40 or Aβ42 cleaved from the familial British and Danish Dementia-related BRI protein demonstrates that pro duc tion of Aβ40 cannot form aggregates into plaques even by 18 months of age, while a lesser concentration of Aβ42 induces ro bust plaque formation even at 12 months of age. Furthermore, the BRI-Aβ42 mice crossed with APP Tg2576 mice bearing the "Swedish" mutation exponentially exacerbates amyloid plaque forma tion . Second, Aβ can exist as soluble monomers, dimers, trimers, and higher order oligomers (also kno wn as Aβ-derived diffusible ligands; ADDLs) prior to forming protofibrils and insoluble amyloid fibrils. These pathological solu ble Aβ oligomers cause synaptic dysfunction to neurons even at picomolar concentrations. Studies have shown that SDS-stable di mers and trimers derived from the 7PA2 cell line ex pre s s ing an FAD APP mutation impair long term potentiation (LTP), the physiological correlate of learning and memory, at sub na- no mo lar concentrations (Walsh et al., 2002) . Furthermore, solu ble SDS-resistant Aβ dimers derived from AD brains lead to hy perphosphorylation of tau and neuritic degeneration in primary hippocampal neurons at picomolar concentrations . Recently, a new mutation in APP was identified in a Japanese family with AD-type dementia. This mutation occurred as a deletion of residue 22 (glutamic acid) of the Aβ peptide (E22Δ). Biochemically, the E22Δ mutation is more resistant to de gradation, unable to form fibrils, but far more prone to selfasso ciation as Aβ oligomers in the form of SDS-stable dimers and trimers (Tomiyama et al., 2008) . Expression of this APP mutation in transgenic mice leads to learning and memory deficits associated with impaired LTP, enhanced neuroinflammation, and tau hyperphosphorylation in the absence of any thioflavin S positive amyloid plaques. However, accumulation of intracellular E22Δ Aβ oligomers are detected in an age-dependent fashion, in di cating that Aβ oligomers are sufficient and fibrillar amyloid de position is not necessary for Aβ-induced neurotoxicity and lear ning and memory deficits (Nishitsuji et al., 2009 ). Indeed, a recent study showed that highly compacted amyloid plaques may actually be protective. Loss of one copy of IGF-1 receptor, which lengthens lifespan, was shown to be protective by promoting faster aggregation of Aβ and increasing the density of amyloid plaques, thereby sequestering toxic soluble Aβ oligomer species into amyloid fibrils (Cohen et al., 2009) . While it appears that amyloid fi b rils per se might be less neurotoxic than soluble Aβ oligomers, it is important to note that amyloid fibrils can disaggregate into so lu ble Aβ oligomers, and thus, may serve as stable sources of these neuro toxic species.
Numerous studies have shown that Aβ promotes the hyperphosphorylation of tau in vitro and in vivo (Avila et al., 2004; Gendron and Petrucelli, 2009 ). Furthermore, Aβ also increases the number of neurofibrillary tangles in transgenic mice engineered to exp ress a Frontotemporal Dementia (FTDP-17) tau mutation (Lewis et al., 2001 ). Moreover, depletion of Aβ by injection of an anti body directed against Aβ also leads to reduced tau pa tho logy in the APP/ tau/presenilin-1 mutant triple transgenic mice (Oddo et al., 2004) , further supporting the model that Aβ pro motes tau pathology in vivo. In addition, recent studies have demon strated that many of the toxic effects of Aβ require tau ex p ression, indicating that tau is indeed downstream of Aβ-in du ced neurotoxic signals. Neurite retraction and progressive neuronal atrophy are seen when neu rons are treated with Aβ but not in neurons derived from tau knockout mice (Rapoport et al., 2002; Jin et al., 2011) . Furthermore, learn ing and memory impairment as well as high sensitivity to exci to toxin treatment are present in mutant APP transgenic mice but not in the same transgenic mice on a tau homozygous knock out background, even though the level of Aβ deposition is unaffected by tau (Roberson et al., 2007). Importantly, Aβ induces impairments in LTP and axonal transport of mitochondria; how ever, such impairments are not seen in tau knockout neurons (Shipton et al., 2011; Vossel et al., 2011) , indicating that tau is re qui red for multiple facets of Aβ-induced neurotoxicity. These re sults all indicate that Aβ-in du ced toxic signals are transmitted via tau. But what might be a me chani sm of tau in Aβ/ tau-mediated neurotoxicity? A recent study de monstrated that Aβ oligomers ra pidly lead to disassembly of microtubules but only in cells exp ressing tau (King et al., 2006) . This is particularly important in brain, because tau is highly expre s sed in neurons. Furthermore, the microtubule network is critical for such processes as axonal transport and ultimately synaptic trans mission. One of the earliest changes in tau pathology seen in AD is the mislocalization of tau from somatoaxonal to so ma to den dritic compartments (Avila et al., 2004; Gendron and Petrucelli, 2009 ). An important study recently demonstrated that hyperphosphorylation of tau is linked to reduced affinity for micro tubules and mislocalization into den dritic spines where tau induces removal of various AMPA and NMDA receptors critical for excitatory synaptic transmission. Loss of tau phosphorylation fails to mislocalize tau into dendritic spines and affect excitatory synaptic transmission (Hoover et al., 2010) . Therefore, Aβ-induced hyperphosphorylation of tau appears to explain both microtubule disassembly and impaired excitatory synaptic transmission. It is im portant to note that, like soluble Aβ oligomers, soluble hyperphos phorylated tau rather than PHF tau may be the toxic species, since turning off FTD mu tant tau expression in an inducible transgenic model does not remove insoluble PHF-1 positive tangle-like structures over several months but improves learning and memory (Santacruz et al., 2005 (Calkins and Reddy, 2011) . A recent study demonstrated early deficits in synaptic mitochondria in FAD mutant APP transgenic mice: 1) synaptic mitochondrial dysfunction, 2) Aβ accumulation within mitochondria prior to extracellular Aβ deposition, and 3) impaired axonal transport of mitochondria (Du et al., 2010) . Synapses are relatively more susceptible to Aβ-induced neurotoxicity, which is not surprising, because Aβ is mainly released by and accumulates in synapses (Mattson, 2004) . Aβ induces Ca 2+ dysregulation by membraneassociated oxidative stress and activates calcineurin, an important mediator of synaptic plasticity (Celsi et al., 2007) . In addition, Aβ induces synaptic dystrophy and dysregulation at least in part due to decreased expression of NMDA and EphB2 receptors at the synapse, an event that can be corrected by NMDAR agonists (Lacor et al., 2007) . Though the exact mechanisms of ROS-induced synaptic degeneration remain to be further elucidated, ROS is well known to play important roles in synaptic plasticity. Indeed, oxidation of cysteine residues on RynR increases Ca 2+ release from the ER (Hidalgo, 2005) and oxidation of the same residues on NMDAR decreases the receptor activity (Lipton et al., 2002) . Therefore, it appears that Aβ induces synaptic deficits via both increasing oxidative damage and dysregulating Ca 2+ dynamics at the synapse and mitochondria, both of which cooperatively contribute to neurodegeneration in AD. Tau pathology is also linked to mitochondrial dysfunction. Transgenic mice over-expressing the P301L mutant demonstrate a signi ficant reduction in complex V and NADH-ubiquinone oxidoreductase activity together with impairments in mitochondrial www.enjournal.org http://dx.doi.org/10.5607/en.2011.20.2.67 res piration and ATP synthesis (David et al., 2005) . Tau can be cleaved by caspases 3, 7, and 8 after Asp-421, yielding a 421 residue tau fragment that assembles into PHF-like fibrils more rapidly than full length tau. Overexpression of this cleaved tau leads to a significant decrease in mitochondrial membrane potential and loss of mitochondrial membrane integrity (Quintanilla et al., 2009 ). Moreover, introduction of tau in mature hippocampal neu rons results in degeneration of synapses by perturbing mitochondria transport and ATP levels at the synapse (Thies and Mandelkow, 2007) . N-terminal tau fragments have toxic effects on mitochondria and lead to the mitochondrial dysfunction asso ci a ted with impairments in oxidative phosphorylation by di stor ting the enzyme structure of complex V and the level of ade nine nucleotide translocator, which ultimately perturbs ATP synthesis in mitochondria (Atlante et al., 2008 knockout mice, such Aβ-induced degeneration of the basal forebrain is not observed (Yaar et al., 1997) . Therefore, targeting the Aβ/p75NTR interaction appears to represent a promising the rapeutic strategy, especially for the cholinergic system. However in this review, we will focus on the integrin adhesion receptors, as Aβ mediates its neurotoxicity via binding to multiple integrins, which are highly enriched throughout the brain. The integrin family mediates both cell-cell and cell-substratum adhesion by binding their extracellular ligands such as laminin and fibronectin. Integrins consist of an α and a β subunit, and each subunit has a large extracellular portion, a single transmembrane segment, and a short cytoplasmic tail (Hynes, 1992) . These cytoplasmic tails bind to intracellular ligands to mediate dynamic cellular responses, such as cell adhesion, migration, neurogenesis, apoptosis, and synaptic stability. Hence, integrins provide a transmembrane link for the bidirectional transmission of signals across the plasma membrane by binding both extracellular and intracellular ligands (Zamir and Geiger, 2001 ). The ability to connect to the actin cytoskeleton is an important part of the adhesive function of the integrin family. Within focal adhesions, structural proteins such as vinculin and talin anchor β-integrins to the actin cytoskeleton, while signaling proteins such as focal adhesion kinase (FAK), Pyk2, Paxillin, and Src mediate downstream signaling events in a transient and controlled manner (Cabodi et al., 2010) . Integrin signaling is also associated with changes in synaptic plasticity and neuronal excitability. Glutamate receptors (NMDA and AMPA receptors) are the target of integrindependent regulation. Interfering with integrin-dependent adhesion by antagonists or conditional deletion of α3, α5, and/ or β1 integrins leads to defective LTP (Becchetti et al., 2010) . Therefore, integrins represent important adhesion receptors that can regulate multiple facets of neuronal function and viability.
Multiple studies have shown that Aβ can bind to a number of di fferent integrins, a process that can lead to both protective and neurotoxic outcomes. α5/β1-integrin has been shown to exert an anti-apoptotic role. Adhesion by α5/β1-integrin upregulates Bcl-2 and is one of the few integrins that activates the signaling protein Shc. Matter and colleagues showed that α5/β1-integrin binds to nonfibrillar but not fibrillar Aβ1-40 and reduces the for mation of insoluble fibrillar Aβ via internalization of Aβ and partial degradation, an effect that is blocked by an antibody aga inst α5-integrin. Overexpression of α5/β1-integrin protects from Aβ-induced apoptosis (Matter et al., 1998 On the other hand, multiple studies have shown that several integrins are also required for Aβ-induced toxicity. Integrin blocking antibodies to α1/β1 or echistatin (a highly selective and potent integrin inhibitor) blocks fibrillar Aβ-induced MAPK activation and Aβ-induced neurotoxicity in primary neuronal cultures (Anderson and Ferreira, 2004). Moreover, antibodies against αv-integrins block the inhibition in LTP induced by Aβ. In addition, a small molecule nonpeptide antagonist of αv-containing integrins (SM256) and a potent disintegrin echistatin also block Aβ-induced inhibition of LTP. Accordingly, a potent ligand of αv/ β1 integrin, superfibronectin, also efficiently inhibits Aβ-induced inhibition of LTP . As glutamate receptors are targets of integrin-mediated regulation, it is likely that integrinmediated alterations in glutamate receptors underlie Aβ-induced inhibition of LTP. Addition of soluble Aβ together with fibrillar Aβ dramatically enhances the meshwork of Aβ deposition on cortical neurons and induces neurotoxicity in an α2/β1 and αv/β1 integrin dependent manner (Wright et al., 2007) . Antibodies against β1, α2, and αv but not α1, α3, α4, α5, α6, α9, αv/β 3, αv/β5, or β3 integrins inhibit Aβ-induced neurotoxicity in human primary neurons (Wright et al., 2007) . Aβ elicits a sustained phosphorylation of pyk2-associated paxillin, which correlates with neurotoxicity. Expression of a dominant negative Pyk2 abolishes Aβ-induced neurotoxicity, and αv/β1 ligands (fibronectin, superfibronectin, and vitronectin) as well as α2/β1 ligands (collagen and laminin) all block Aβ-induced neurotoxicity, presumably via competing with Aβ binding to these receptors (Wright et al., 2007) . Interestingly, both actin stabilizing compounds (jasplkinolide) and destabilizing compounds (cytochalasin D and latrunculin A) also inhibit Aβ-induced neurotoxicity, indicating that downstream actin remodeling is critical for this effect (Wright et al., 2007) . Perlecan domain V, which binds to α2-integrin, competitively inhibits Aβ binding to cells as well as Aβ-induced neurotoxicity (Wright et al., 2010) . α2 null cells significantly bind less Aβ than wild type cells, and Aβ binds more efficiently to cell expressing the activated form of α2-integrin (Wright et al., 2010) . All of these findings taken together indicate that Aβ binding to various integrins, especially α2, β1, and αv, are required for the complement of Aβ-induced neurotoxicity. However, the normal engagement of integrins to their cognate physiological matrix substrates appears to be protective for a couple of reasons. First, the physiological substrates compete out the binding of Aβ to integrins, and second, they mediate normal and tightly regulated integrin activation and downstream signaling. Integrin activation and downstream focal adhesion signaling (FAK, Pyk2, Paxillin, and Src) induced by Aβ binding to integrins is not well characterized but appears to be a prolonged and dysregulated, unlike that seen with physiological substrates (Wright et 
COFILIN, A CENTRAL NEXUS OF CYTOSKELETAL CHANGES, MITOCHONDRIAL DYSFUNCTION, AND TAU PATHOLOGY IN NEURODEGENERATIVE DISEASES?
Integrins, mitochondrial dysfunction, cytoskeletal perturbations, and tau phosphorylation are key elements of Aβ-induced neurotoxicity. However, what critical downstream intracellular factors relay the Aβ neurotoxic signals to the mitochondria, cytoskeleton, and tau? The assembly and disassembly of G-actin to F-actin is a process critical to many cellular processes, including cell motility, migration, dendritic spine morphogenesis, and membrane protein endocytosis (Bernstein and Bamburg, 2010) . ADF/Cofilin, a family of actin-binding protein, is perhaps one of the key regulators of actin dynamics. Cofilin differentially modulates actin dynamics depending on the ratio of cofilin to actin. At low cofilin to actin ratios, cofilin acts to sever actin filaments, whereas at high cofilin to actin ratios, cofilin e. fibronectin or laminin) or reelin activates various focal adhesion signaling proteins (i.e. paxillin, FAK, Src, and PI3K), leading to the activation of the Rac-PAK pathway. PAK activates LIMK which phosphorylates cofilin on serine-3. This phosphorylation inactivates cofilin, thereby transiently reducing actin dynamics. The engagement of normal physiological ligands such as reelin with the integrin/APP/LRP complexes (A) simultaneously slows down APP endocytosis, thereby reducing Aβ generation. As the binding of Aβ to various integrins is critical to transmit its neurotoxic signals, Aβ oligomers may displace normal integrin ligands, thereby transmitting defective or aberrant focal adhesion signals, eventually leading to defects in PAK activation. In appropriate or reduced PAK signaling fails to activate LIMK, thereby reducing cofilin phosphorylation. Under conditions of oxidative stress induced by Aβ oligomers or hyperphosphorylated tau, cofilin and 14-3-3ζ is oxidized leading to activation of SSH and further activation of cofilin. Oxidized and dephosphorylated cofilin translocates into the mitochondria to open up the mitochondrial permeability transition pore, an event that is required for oxidant-induced cell death. Cofilin translocation into mitochondria induces mitochondrial dysfunction, thereby further increasing ROS and calcium dysregulation. Calcium dysregulation by Aβ, tau, and/or cofilin also activates calcineurin, which then leads to SSH activation and further cofilin activation. Activated cofilin can lead to the formation of cofilin-actin rods or aggregates, which attracts hyperphosphorylated tau and promote tau pathology. At the same time, the binding of RanBP9 to APP/ LRP/integrin complexes accelerates APP endocytosis and enhances Aβ generation, thereby further propagating Aβ-induced neurotoxic signaling. (Fig. 1) . Cofilin does not only play a key role in regulating actin dynamics but also mediates a critical function in oxidative stress-induced cell death via an essential mitochondrial mechanism (Chua et al., 2003; Klamt et al., 2009 ). Upon oxidative stress, cofilin becomes oxidized on several cysteine residues (Klamt et al., 2009 ). This causes cofilin to lose its affinity for actin and to translocate into the mitochondria, where it induces swelling, drop in mitochondrial membrane potential, and cytochrome c release by promoting the opening of the permeability transition pore (PTP) (Klamt et al., 2009 ). Interestingly, this occurs independently of Bax. In addition to cofilin oxidation, dephosphorylation (or activation) of cofilin is required for its translocation to the mitochondria and oxidantinduced apoptosis. When oxidation of cofilin is prevented, oxidant induced apoptosis is also inhibited. Furthermore knockdown of endogenous cofilin by siRNA also inhibits both oxidant and staurosporin induced apoptosis, indicating that cofilin is critical for mitochondria-mediated apoptosis (Chua et al., 2003; Klamt et al., 2009 ). Interestingly, inhibition of actin dynamics is associated with increased ROS production and reduced mitochondrial membrane potential (Gourlay and Ayscough, 2005) , both of which can further contribute to cofilin-mediated mitochondrial dysfunction. Therefore, dysregulation of cofilin itself, which leads to inhibition of actin dynamics, can lead to increased ROS levels and mitochondrial dysfunction. Cellular stimuli that generate ROS not only oxidize cofilin to promote mitochondrial dysfunction but also activate SSH via oxidation of 14-3-3ζ, a chaperone protein that normally functions to inhibit SSH in the nonoxidized form (Kim et al., 2009 , ROS, and focal adhesion signaling can also induce the activation of cofilin, which in turn, dysregulates cytoskeletal dynamics, mitochondria, and tau (Fig. 1B) .
One of the pronounced features of multiple neurodegenerative diseases, including AD, is the accumulation of filamentous rodlike structures that contain cofilin and actin (i.e. cofilin-actin rods). These inclusions are prominently found in hippocampal and cortical tissues of AD brains and transgenic mouse models of AD but are missing in normal brains (Maloney and Bamburg, 2007) . Under stressful situations such as ATP depletion, excitotoxicity, or ROS overproduction, cofilin-actin rods form in tandem array in neurites of primary neurons (Minamide et Huntington' s disease (HD) is one of the polyglutamine dis order caused by CAG repeat expansion in the exon 1 of the hun ting tin (Htt) gene. Mutant huntingtin forms aggregates in the cy to plasm and nucleus and negatively affects neuronal via bi li ty, leading to the degeneration of the striatum manifested cli ni cally by uncontrollable involuntary movements (Spokes, 1980) . Mitochondrial dysfunction has long been associated with neurodegeneration in HD. 3-Nitro propionic acid, an inhibitor of the mitochondrial citric acid cycle, leads to a selective degeneration of the striatum similar to that seen in HD (Borlongan et al., 1997) . Many studies have shown that mutant Htt associates with mitochondria and causes impairments in mitochondrial function as well as inhibition of vesicular axonal trafficking and mitochondrial motility (Panov et al., 2002; Trushina et al., 2004; Orr et al., 2008) . It has also been shown that mutant Htt induces nuclear rods similar to the cofilinactin rods seen in AD (Munsie et al., 2011) .
The involvement of mitochondrial dysfunction and pertur ba tions in the cytoskeleton and cofilin are common themes in various diffe rent neurodegenerative diseases, including AD, FTD, PD, and HD. Although Aβ accumulation is unique to AD, pathogenic intracellular proteins such as tau, α-synuclein, and huntingtin all promote cytoskeletal aberrations and mitochondrial dysfunction. Thus, whether neurotoxic signals are derived from an extracellular source (i.e. Aβ) or from within the neuron, mitochondria and cyto skeleton appear to be the primary targets of neurodegenerative processes. In AD, Aβ induces mitochondrial dysfunction, calcium dysregulation, ROS generation, and cytoskeletal aberrations via binding to integrins and hyperphosphorylation of tau. In view of the findings that cofilin regulates and is regulated by each of these key events, we hypothesize that cofilin acts as a central nexus regulating the pathogenesis and neurodegenerative changes seen in AD and related disorders. Therefore, the regulation of cofilin activity from the cell surface (i.e. Aβ binding to integrins or other receptors) or from inside neurons (i.e. ROS, Ca
2+
, and focal adhesion signal regulation) and/or its physical interactions with the mitochondria, cytoskeleton, focal adhesion complexes, and/ or tau may be attractive therapeutic targets for neurodegenerative diseases.
